Clinical Trials Browser

Interventional × Recurrence × Fulvestrant × Clear all

NCT06105632 2026-02-13

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Phase 2 Active not recruiting

Breast Neoplasms, Recurrence

NCT00256698 2012-08-01

FACT

Phase 3 Completed

514 enrolled 13 charts

Breast Neoplasms, Neoplasms, Recurrence

NCT00334295 2012-07-31

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Phase 2 Completed

35 enrolled 9 charts

Recurrence, Endometrial Neoplasms